Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
28.08.24
/
50%
€0.24
Target price
28.08.25
€69.28
Performance (%)
3.36%
Price
28.08.24
€0.25
Summary
This prediction is currently active. The BUY prediction by BTIG_Research shows slight gains of 3.36%. This prediction currently runs until 28.08.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Galmed Pharmaceuticals Ltd. | 3.36% |
iShares Core DAX® | 1.743% |
iShares Nasdaq 100 | -2.088% |
iShares Nikkei 225® | 1.306% |
iShares S&P 500 | -0.093% |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $75.00 to $77.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
16.07.24
16.07.24
€68.81
16.07.25
16.07.25
-5.93%
28.08.24
28.08.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.33
29.05.24
29.05.24
€66.36
29.05.25
29.05.25
-25.90%
28.08.24
28.08.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.36
08.05.24
08.05.24
€58.61
08.05.25
08.05.25
-32.04%
28.08.24
28.08.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.30
18.03.24
18.03.24
€55.09
18.03.25
18.03.25
-16.89%
28.08.24
28.08.24